Treatment of the Serotonin Syndrome with Cyproheptadine

Authors:
  • RLRichard I. Lappin
    Richard I. Lappin
  • EAElizabeth L. Auchincloss
    Elizabeth L. Auchincloss

Abstract
The serotonin syndrome consists of behavioral, neuromuscular, and autonomic changes that result from increased activity of serotonin (5-hydroxytryptamine) in the central nervous system.1 Its symptoms and signs include confusion, fever, diaphoresis, hyperreflexia, ataxia, and myoclonus. The syndrome usually results from the concurrent use of two serotonergic medications, most often a monoamine oxidase inhibitor and either tryptophan or an inhibitor of serotonin reuptake, such as fluoxetine (Prozac) or sertraline (Zoloft). Because of the long-lasting serotonergic activity of both monoamine oxidase inhibitors and inhibitors of serotonin reuptake, however, the syndrome can occur when one drug is discontinued and the other is started weeks later. With supportive therapy alone, the syndrome usually resolves completely within 24 hours after discontinuation of the drug, but prolonged symptoms and even fatal outcomes have occurred.

This publication has 2 references indexed in Scilit: